• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种评估绝经后女性生活质量的新方法。

A new methodological approach to the evaluation of quality of life in postmenopausal women.

作者信息

Wiklund I, Holst J, Karlberg J, Mattsson L A, Samsioe G, Sandin K, Uvebrant M, von Schoultz B

机构信息

Department of Medicine, Ostra Hospital, Göteborg, Sweden.

出版信息

Maturitas. 1992 Mar;14(3):211-24. doi: 10.1016/0378-5122(92)90116-l.

DOI:10.1016/0378-5122(92)90116-l
PMID:1508061
Abstract

An approach employing a range of standardized questionnaires, which included the Nottingham Health Profile (NHP), the Psychological General Well-Being (PGWB) index and the Mood Adjective Check List (MACL), was used to assess health-related quality of life (QoL) in conjunction with a study comparing two doses of transdermal oestrogen (50 or 100 micrograms/24 h) combined with an oral progestogen (5 mg medroxyprogesterone acetate for 14 days each cycle). In addition to the QoL measures, climacteric symptoms were self-rated and also summarized by means of the Kupperman index. In all, 59 women, median age 52 (39-71) years, who completed 4 months of therapy were evaluated. The use of a battery of standardized questionnaires enabled a comprehensive evaluation to be made of perceived health, well-being and day-to-day functioning. Not only was symptomatic relief, e.g. reduced frequency of sweating episodes, sleep disturbance and hot flushes, observed during treatment, but there were also improvements in terms of sleep, energy and emotions. The frequency of health-related problems associated with paid employment, housework, social life, home life and sex life decreased, indicating enhanced ability to take part in daily activities. The PGWB index showed improvement in the subscales representing well-being, anxiety, depression, vitality, health and self-control, while the mood scales indicated that the women experienced less tension and more satisfaction. Although the results of this study need to be further documented on the basis of a placebo-controlled trial, the findings nevertheless imply that the use of a battery of standardized questionnaires optimizes the possibility of evaluating climacteric complaints reliably before and after treatment.

摘要

采用一系列标准化问卷的方法来评估与健康相关的生活质量(QoL),这些问卷包括诺丁汉健康量表(NHP)、心理总体幸福感(PGWB)指数和情绪形容词检查表(MACL),该方法同时用于一项比较两种剂量经皮雌激素(50或100微克/24小时)与口服孕激素(每个周期14天服用5毫克醋酸甲羟孕酮)的研究。除了生活质量测量指标外,更年期症状由患者自评,并通过库珀曼指数进行汇总。共有59名年龄中位数为52(39 - 71)岁且完成了4个月治疗的女性接受了评估。使用一系列标准化问卷能够对感知到的健康、幸福感和日常功能进行全面评估。在治疗期间不仅观察到症状缓解,例如出汗发作频率降低、睡眠障碍和潮热减轻,而且在睡眠、精力和情绪方面也有改善。与有偿工作、家务、社交生活、家庭生活和性生活相关的健康问题频率降低,表明参与日常活动的能力增强。PGWB指数显示在代表幸福感、焦虑、抑郁、活力、健康和自我控制的子量表上有所改善,而情绪量表表明这些女性的紧张感减轻且满意度更高。尽管本研究的结果需要在安慰剂对照试验的基础上进一步记录,但这些发现仍然意味着使用一系列标准化问卷优化了在治疗前后可靠评估更年期症状的可能性。

相似文献

1
A new methodological approach to the evaluation of quality of life in postmenopausal women.一种评估绝经后女性生活质量的新方法。
Maturitas. 1992 Mar;14(3):211-24. doi: 10.1016/0378-5122(92)90116-l.
2
Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women.经皮激素疗法对绝经后女性生活质量各方面的长期影响。
Maturitas. 1992 Mar;14(3):225-36. doi: 10.1016/0378-5122(92)90117-m.
3
The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.复合生物等效透皮激素疗法对围绝经期和绝经后女性的止血、炎症、免疫因子、心血管生物标志物、生活质量指标及健康结局的影响。
Int J Pharm Compd. 2013 Jan-Feb;17(1):74-85.
4
Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study.接受经皮雌二醇治疗方案的绝经后女性的生活质量:一项双盲安慰剂对照研究。
Am J Obstet Gynecol. 1993 Mar;168(3 Pt 1):824-30. doi: 10.1016/s0002-9378(12)90828-5.
5
Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints.雌激素疗法对无血管舒缩症状的绝经后女性幸福感的影响。
Maturitas. 2000 Aug 31;36(2):123-30. doi: 10.1016/s0378-5122(00)00141-9.
6
Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.经皮雌激素联合左炔诺孕酮宫内节育器治疗更年期症状:临床及子宫内膜反应
Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):114-9. doi: 10.1016/0002-9378(95)90095-0.
7
[Influence of hormone replacement therapy on the quality of life in postmenopausal women with hypertension].[激素替代疗法对绝经后高血压女性生活质量的影响]
Przegl Lek. 2000;57(7-8):397-401.
8
Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.一种新型活性基质雌二醇透皮贴剂与对照贮库型贴剂对更年期症状的疗效比较。两项长期随机多中心平行组研究。
Arzneimittelforschung. 1999 Nov;49(11):933-43. doi: 10.1055/s-0031-1300529.
9
Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy.有或无潮热症状女性的健康相关生活质量:一项激素治疗的随机安慰剂对照试验
Menopause. 2014 Jul;21(7):732-9. doi: 10.1097/GME.0000000000000120.
10
Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.连续联合激素替代疗法可缓解绝经后早期女性的更年期症状并改善健康相关生活质量。
Menopause Int. 2007 Sep;13(3):116-23. doi: 10.1258/175404507781605622.

引用本文的文献

1
Sleep-light interventions that shift melatonin rhythms earlier improve perimenopausal and postmenopausal depression: preliminary findings.睡眠轻干预可使褪黑素节律提前,改善围绝经期和绝经后抑郁症:初步研究结果。
Menopause. 2023 Aug 1;30(8):798-806. doi: 10.1097/GME.0000000000002216. Epub 2023 Jul 18.
2
Benign Paroxysmal Positional Vertigo Risk Factors Unique to Perimenopausal Women.围绝经期女性特有的良性阵发性位置性眩晕风险因素
Front Neurol. 2020 Oct 16;11:589605. doi: 10.3389/fneur.2020.589605. eCollection 2020.
3
Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
长期使用洋甘菊(母菊)治疗广泛性焦虑症:一项随机临床试验。
Phytomedicine. 2016 Dec 15;23(14):1735-1742. doi: 10.1016/j.phymed.2016.10.012. Epub 2016 Oct 24.
4
Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract for generalized anxiety disorder.在一项针对广泛性焦虑症的洋甘菊提取物试验中,特定的预期与症状性结果及副作用负担相关。
J Psychiatr Res. 2017 Jan;84:90-97. doi: 10.1016/j.jpsychires.2016.09.029. Epub 2016 Sep 30.
5
Rhodiola rosea therapy for major depressive disorder: a study protocol for a randomized, double-blind, placebo- controlled trial.红景天治疗重度抑郁症:一项随机、双盲、安慰剂对照试验的研究方案
J Clin Trials. 2014 Jun 20;4:170. doi: 10.4172/2167-0870.1000170.
6
Factors associated with successful discontinuation of hormone therapy.与成功停止激素治疗相关的因素。
J Womens Health (Larchmt). 2014 May;23(5):382-8. doi: 10.1089/jwh.2012.4200. Epub 2014 Jan 20.
7
Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.乳腺癌幸存者热潮红的药物和非激素治疗:CEPO 综述和建议。
Support Care Cancer. 2013 May;21(5):1461-74. doi: 10.1007/s00520-013-1732-8. Epub 2013 Feb 23.
8
Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial.短期激素治疗中断后出现睡眠问题:一项随机试验的二次分析。
Menopause. 2011 Nov;18(11):1184-90. doi: 10.1097/gme.0b013e31821d6d33.
9
Sleep Complaints of Postmenopausal Women.绝经后女性的睡眠问题
Clin J Womens Health. 2001 Dec 1;1(5):244-252. doi: 10.1053/cjwh.2001.30491.
10
Non-hormonal treatment strategies for vasomotor symptoms: a critical review.非激素治疗策略治疗血管舒缩症状:批判性评价。
Drugs. 2011 Feb 12;71(3):287-304. doi: 10.2165/11585360-000000000-00000.